Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.

Source:http://linkedlifedata.com/resource/pubmed/id/16621899

Download in:

View as

General Info

PMID
16621899